Steroids for optic nerve diseases?;Steroide bei Sehnerverkrankungen?

Ophthalmologe

Volumn 104, Issue 6, 2007, Pages 517-520

  Lagreze W A ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Optic nerve neuritis; Steroids; Traumatic optic neuropathy (TON)

Indexed keywords

EID: 34547365939     PISSN: 0941293X     EISSN: 14330423     Source Type: Journal    
DOI: 10.1007/s00347-007-1525-x     Document Type: Article

References (30)

1. Optic Neuritis Study Group (1997) The 5-year risk of MS after optic neuritis. Experience of the optic neuritis treatment trial. Neurology 49: 1404-1413
2. Beck RW, Cleary PA, Anderson MM Jr et al. (1992) A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group. N Engl J Med 326:581-588
3. Beck RW, Gal RL, Bhatti MT et al. (2004) Visual function more than 10 years after optic neuritis: experience of the optic neuritis treatment trial. Am J Ophthalmol 137: 77-83
4. Bracken MB, Shepard MJ, Collins WE et al. (1990) A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinalcord injury. Results of the Second National Acute Spinal Cord Injury Study. N Engl J Med 322: 1405-1411
5. Bracken MB, Shepard MJ, Holford TR et al. (1997) Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. National Acute Spinal Cord Injury Study. JAMA 277: 1597-1604
6. Diem R, Hobom M, Maier K et al. (2003) Methylprednisolone increases neuronal apoptosis during autoimmune CNS inflammation by inhibition of an endogenous neuroprotective pathway. J Neurosci 23: 6993-7000
7. Falkenstein E, Tillmann HC, Christ M et al. (2000) Multiple actions of steroid hormones-a focus on rapid, nongenomic effects. Pharmacol Rev 52: 513-556
8. Frohman E, Costello F, Zivadinov R et al. (2006) Optical coherence tomography in multiple sclerosis. Lancet Neural 5: 853-863
9. Gelati M, Corsini E, De Rossi M et al. (2002) Methylprednisolone acts on peripheral blood mononuclear cells and endothelium in inhibiting migration phenomena in patients with multiple sclerosis. Arch Neurol 59: 774-780
10. Gold R, Buttgereit F, Toyka KV (2001) Mechanism of action of glucocorticosteroid hormones: possible implications for therapy of neuroimmunological disorders. J Neuroimmunol 117: 1-8
11. Gould ES, Bird AC, Leaver PK, McDonald WI (1977) Treatmenf of optic neuritis by retrobulbar injection oftriamcinolone. Br Med J 1: 1495-1497
12. Hickman SJ, Kapoor R, Jones SJ et al. (2003) Corticosteroids do not prevent optic nerve atrophy following optic neuritis. J Neurol Neurosurg Psychiatry 74: 1139-1141
13. Kapoor R, Miller DH, Jones SJ et al. (1998) Effects of intravenous methylprednisoloneon outcome in MRI-based prognostic subgroups in acute optic neuritis. Neurology 50: 230-237
14. Kappos L, Antel J, Comi G et al. (2006) Oral fingolimod (FTY720) for relapsing multiple sclerosis. N Engl J Med 355: 1124-1140
15. Levin LA, Beck RW, Joseph MP et al. (1999) The treatment of traumatic optic neuropathy: the International Optic Nerve Trauma Study. Ophthalmology 106: 1268-1277
16. McDonald WI, Compston A, Edan G et al. (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 50: 121-127
17. Ohlsson M, Westerlund U, Langmoen IA, Svensson M (2004) Methylprednisolone treatment does not influence axonal regeneration or degeneration following optic nerve injury in the adult rat. J Neuroophthalmol 24: 11-18
18. Polman CH, Reingold SC, Edan G et al. (2005) Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria".Ann Neurol 58: 840-846
19. Rhen T, Cidlowski JA (2005) Antiinflammatory action of glucocorticoids-new mechanisms for old drugs. N Engl J Med 353: 1711-1723
20. Roberts I, Yates D, Sandercock P et al. (2004) Effect of intravenous corticosteroids on death within 14 days in 10008 adults with clinically significant head injury (MRC CRASH trial): randomised placebo-controlled trial. Lancet 364: 1321-1328
21. Steel DH, Waldock A (1998) Measurement of the retinal nerve fibre layer with scanning laser polarimetry in patients with previous demyelinating optic neuritis. J Neurol Neurosurg Psychiatry 64: 505-509
22. Steinsapir KD (2006) Treatment of traumatic optic neuropathy with high-dose corticosteroid. J Neuroophthalmol 26: 65-67
23. Steinsapir KD, Goldberg RA, Sinha S, Hovda DA (2000) Methylprednisolone exacerbates axonal loss following optic nerve trauma in rats. Restor Neurol Neurosci 17: 157-163
24. Trapp BD, Peterson J, Ransohoff RM et al. (1998) Axonal transection in the lesions of multiple sclerosis. N Engl J Med 338: 278-285
25. Trautner C, Haastert B, Richter B et al. (2003) Incidence of blindness in southern Germany due to glaucoma and degenerative conditions. Invest Ophthalmol Vis Sci 44: 1031-1034
26. Trauzettel-Klosinski S, Diener HC, Dietz K, Zrenner E (1995) The effect of oral prednisolone on visual evoked potential latencies in acute optic neuritis monitored in a prospective, randomized, controlled study. Doc Ophthalmol 91: 165-179
27. Trip SA, Schlottmann PG, Jones SJ et al. (2005) Retinal nerve fiber layer axonal loss and visual dysfunction in optic neuritis. Ann Neurol 58: 383-391
28. Trip SA, Schlottrnann PG, Jones SJ et al. (2006) Quantification of optic nerve head topography in optic neuritis: a pilot study. Br J Ophthalmol 90: 1128-1131
29. Vedula S, Brodney-Folse S, Gal R, Beck R (2007) Corticosteroids for treating optic neuritis. Cochrane data base of systematic reviews. (Online): CD001430
30. Wakakura M, Mashimo K, Oono S et al. (1999) Multicenter clinical trial for evaluating methylprednisolone pulse treatment of idiopathic optic neuritis in Japan. Optic Neuritis Treatment Trial Multicenter Cooperative Research Group (ONMRG). Jpn J Ophthalmol 43: 133-138